产品中心
当前位置：首页>产品中心Anti-ZBTB8OS/ARCH/FITC
货号： bs-18475R-FITC 基本售价： 2980.0 元 规格： 100ul
产品信息
- 产品编号
- bs-18475R-FITC
- 英文名称
- Anti-ZBTB8OS/ARCH/FITC
- 中文名称
- FITC标记的ARCH抗体
- 别 名
- ARCH; ARCH_HUMAN; ARCH2; Archease (ARCH); Archease like protein; MGC62007; OTTHUMP00000036124; Protein archease; Protein ZBTB8OS; ZBTB8OS; Zinc finger and BTB domain containing 8 opposite strand; Zinc finger and BTB domain containing opposite strand protein 8; Zinc finger and BTB domain-containing opposite strand protein 8.
- 规格价格
- 100ul/2980元购买 大包装/询价
- 说 明 书
- 100ul
- 研究领域
- 细胞生物 转录调节因子 锌指蛋白 表观遗传学
- 抗体来源
- Rabbit
- 克隆类型
- Polyclonal
- 交叉反应
- Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit,
- 产品应用
- ICC=1:50-200 IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
- 分 子 量
- 19kDa
- 性 状
- Lyophilized or Liquid
- 浓 度
- 1mg/ml
- 免 疫 原
- KLH conjugated synthetic peptide derived from human ZBTB8OS/
- 亚 型
- IgG
- 纯化方法
- affinity purified by Protein A
- 储 存 液
- 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
- 保存条件
- Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
- 产品介绍
- Function:
Component of the tRNA-splicing ligase complex required to facilitate the enzymatic turnover of catalytic subunit RTCB.Together with DDX1, acts by facilitating the guanylylation of RTCB, a key intermediate step in tRNA ligation.
Subunit:
Component of the tRNA-splicing ligase complex.
Similarity:
Belongs to the archease family.
Database links:Entrez Gene: 339487Human
Entrez Gene: 67106Mouse
Entrez Gene: 297885Rat
SwissProt: Q8IWT0Human
SwissProt: Q505B7Mouse
Unigene: 655921Human
Unigene: 36575Mouse
Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.